Literature DB >> 16939753

Bone mineral content and mineral metabolism during cyclosporine treatment of nephrotic Syndrome.

Michael Freundlich1.   

Abstract

OBJECTIVE: Although cyclosporine (Cy) has been associated with bone loss following transplantation, its effects on bone in growing children are largely unknown. STUDY
DESIGN: Thirty-seven patients (2-16 years of age) with remitting nephrotic syndrome (NS), n = 16 receiving Cy for 39 +/- 27 months and n = 21 without Cy, underwent mineral metabolism and bone turnover assessment. In 28 of 37 patients, bone mineral density (BMD) was obtained while off corticosteroid therapy (Rx).
RESULTS: Urinary calcium (Ca), phosphate (PO(4)), and magnesium (Mg) excretion was normal, but serum Mg was lower in patients receiving Cy (1.8 +/- 0.1 v 1.95 +/- 0.2 mg/dL, P < .05). BMD Z scores were similar at the spine (-0.45 +/- 0.74 v 0.04 +/- 0.9) and femur (-0.17 +/- 0.52 v 0.38 +/- 1.28) with no Z score <-2. Serum bone-specific alkaline phosphatase was normal, and N-telopeptide of type I collagen also normal, was higher on Cy (P < .05). Cumulative prednisone exposure was similar and had no significant effect on height and BMD Z scores. Length of Cy-Rx and time elapsed from onset of NS did not correlate with BMD, height Z score, or markers of bone turnover.
CONCLUSIONS: In growing children with NS, during long-term Cy-Rx urinary wasting of Ca and Mg was absent and bone density was preserved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939753     DOI: 10.1016/j.jpeds.2006.04.060

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children.

Authors:  Anna Wasilewska; Agnieszka Rybi-Szuminska; Walentyna Zoch-Zwierz
Journal:  Pediatr Nephrol       Date:  2010-07-04       Impact factor: 3.714

2.  Bisphosphonates in children with hypercalciuria and reduced bone mineral density.

Authors:  Michael Freundlich; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

3.  Fibroblast growth factor-23 and renin-angiotensin system levels in vitamin-D-dependent rickets type I.

Authors:  Carlos Cuervo; Carolyn L Abitbol; Gaston E Zilleruelo; Michael Freundlich
Journal:  Pediatr Nephrol       Date:  2016-03-03       Impact factor: 3.714

4.  Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.

Authors:  Kristien J Ledeganck; Charlotte Anné; Amandine De Monie; Sarang Meybosch; Gert A Verpooten; Marleen Vinckx; Koen Van Hoeck; Annelies Van Eyck; Benedicte Y De Winter; Dominique Trouet
Journal:  Nutrients       Date:  2018-05-27       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.